Innovent Biologics Inc.
IVBXF | OTC
$9.90
-$1.40 (-12.39%)
At close: Oct 30, 2026, 2:35 PM ET
$9.90
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:00 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | 97.07 | 142.68 | 106.74 | -572.91 | -42.78 | -59.59 | -30.09 | -20.26 | -16.36 | -20.90 | -76.79 |
PEG Ratio | -0.02 | -1.39 | 0.62 | 3.27 | 0.75 | -0.12 | 0.34 | -0.72 | 0.36 | -0.30 | -0.51 |
PS Ratio | 7.63 | 8.99 | 10.61 | 5.95 | 7.45 | 9.86 | 8.38 | 9.84 | 9.54 | 13.36 | 22.73 |
PB Ratio | 5.73 | 6.06 | 8.40 | 4.28 | 4.47 | 4.88 | 3.90 | 4.18 | 4.54 | 5.52 | 9.17 |
P/FCF Ratio | n/a | 11.94 | 74.41 | 174.58 | -83.40 | -62.98 | -15.01 | -15.92 | -14.70 | -18.46 | -78.93 |
P/OCF Ratio | n/a | 11.62 | 62.59 | 43.59 | 100.06 | 413.97 | -24.23 | -23.36 | -23.98 | -28.18 | -188.33 |
OCF/S Ratio | n/a | 136.29 | 7.29 | 27.47 | -5.46 | 21.99 | -23.06 | -48 | -36.02 | -43.36 | -52.30 |
Debt / Equity Ratio | 0.11 | 0.15 | 0.23 | 0.22 | 0.27 | 0.29 | 0.32 | 0.30 | 0.29 | 0.24 | 0.16 |
Quick Ratio | 2.48 | 2.47 | 2.39 | 2.16 | 2.51 | 2.78 | 3.51 | 2.88 | 2.79 | 3.35 | 5.50 |
Current Ratio | 2.68 | 2.62 | 2.61 | 2.35 | 2.68 | 3 | 3.96 | 3.29 | 3.22 | 3.79 | 5.99 |
Asset Turnover | 0.20 | 0.19 | 0.25 | 0.25 | 0.19 | 0.17 | 0.15 | 0.13 | 0.14 | 0.14 | 0.12 |
Interest Coverage | 46.63 | -0.47 | n/a | n/a | n/a | n/a | n/a | n/a | -32.51 | -15.31 | -36.21 |
Return on Equity | 5.96% | -0.11% | 5.79% | 2.27% | -3.16% | -7.09% | -1.29% | -11.45% | -9.91% | -16.70% | -8.43% |
Return on Assets | 2.97% | -0.06% | 3.54% | 1.38% | -1.93% | -4.31% | -0.78% | -6.99% | -5.88% | -10.62% | -6.10% |
Return on Invested Capital | 4.46% | -0.01% | 3.50% | -0.08% | -4.31% | -5.53% | -2.52% | -11.16% | -10.17% | -12.68% | -6.72% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 84.96% | 76.16% | 76.73% | 75.91% | 72.31% | 70.75% | 71.06% | 70.93% | 68.37% | 71.32% | 71.33% |
Net Profit Margin | 14.54% | -0.29% | 14.01% | 5.45% | -9.93% | -25.36% | -5.15% | -53.04% | -42.44% | -74.11% | -51.68% |
Pretax Profit Margin | 18.70% | -0.82% | 15.07% | 5.74% | -9.93% | -25.35% | -9.48% | -50.57% | -44.60% | -70.37% | -51.68% |
Operating Profit Margin | 22.14% | -0.12% | 12.46% | -0.28% | -18.74% | -27.41% | -26.61% | -72.25% | -64.70% | -73.97% | -50.54% |
FCF Margin | n/a | 133.07% | 6.59% | 22.61% | -23.15% | 7.11% | -45.19% | -68.20% | -55.17% | -74.17% | -70.23% |
EBITDA Margin | 25.99% | 5.89% | 14.99% | -4.23% | -6.30% | -21.17% | -20.23% | -66.21% | -60% | -70.20% | -46.54% |
Add to Watchlist
Select watchlists to add or remove IVBXF